LAS VEGAS, July 23, 2014 /PRNewswire/ -- GrowBLOX
Sciences, Inc. (OTCQB: GBLX), a medical cannabis research and
development company, announced today that it is filing for two
medical marijuana dispensary locations in Las Vegas, Nevada. These locations are in
addition to the Clark County,
Nevada dispensary for which the company has received a
special use permit, as previously announced.
GrowBLOX Sciences' CEO Craig
Ellins stated, "We are pleased to be submitting two new
applications for dispensaries in the City
of Las Vegas. We believe that working with our local
partners has produced strong applications and we love our chosen
locations." GrowBLOX strategically chose the two locations in
its latest application to capitalize on future heavy Las Vegas medical tourism.
If approved, the Rainbow-Vista dispensary will be located at
1040 South Rainbow Boulevard, Las
Vegas and the Vegas-Charleston dispensary at 905 South Las
Vegas Boulevard, Las Vegas. Both
locations are in the heart of the city and well-suited for
servicing the medical marijuana patients who are among the 40
million tourists visiting the city each year.
Craig Ellins added, "The
City of Las Vegas and the
State of Nevada have created very
rigorous application processes, which we appreciate because it
brings the standard of operations up to a high level for our
industry. We want to make Nevada our flagship market."
GrowBLOX has already received both a special use permit for a
medical marijuana dispensary in Fort Apache, Nevada (Clark
County) as well as a special use permit for a cannabis
cultivation and conversion facility; also in Clark County, NV. The Company is
awaiting final State approval, expected later this year, for both
the dispensary and the cultivation facility. If both licenses
are granted, and allowing some time for construction, GrowBLOX
expects to be generating revenues from the cultivation and sale of
legal medical cannabis in the second half of 2015.
Mr. Ellins commented, "We anticipate getting a response on our
application for two additional dispensaries in the first quarter of
2015, although the timing of a response is outside of our
control. We are very excited about the prospect of adding to
our Nevada presence. This is
part of our strategy of securing the rights to dispensaries and
grow-sites nationwide. As we've previously announced, we have
similar expansion efforts in Florida, Illinois, New
York and elsewhere. We look forward to updating our
shareholders as we continue to execute on our business
plan."
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company
that has developed proprietary indoor growing chambers specifically
designed for medical cannabis cultivation. The
GrowBLOXTM chamber allows for completely controlled
growing conditions, ensuring the manufacture of a consistent,
toxin-free, natural and medicinal-grade product. The Company
believes that the advantages of a controlled environment over
traditional outdoor or greenhouse growing, will empower the public,
nutraceutical and pharmaceutical industries to embrace cannabis as
an effective treatment for a myriad of serious medical
conditions. http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the statements
in this release are forward-looking and made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements are inherently unreliable
and actual results may differ materially. Examples of
forward-looking statements in this news release include statements
regarding the payment of dividends, marketing and distribution
plans, development activities and anticipated operating
results. Factors which could cause actual results to differ
materially from these forward-looking statements include such
factors as the Company's ability to accomplish its business
initiatives, significant fluctuations in marketing expenses and
ability to achieve and expand significant levels of revenues, or
recognize net income, from the sale of its products and services,
as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary for
the development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
Contact:
Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105
SOURCE GrowBLOX Sciences, Inc.